JGVRX | VIGRX | JGVRX / VIGRX | |
Total Expense Ratio | 0.60 | 0.17 | 353% |
Annual Report Gross Expense Ratio | 0.68 | 0.17 | 400% |
Fund Existence | 16 years | 32 years | - |
Gain YTD | -12.909 | -12.182 | 106% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18.3B | 261B | 7% |
Annual Yield % from dividends | 0.00 | 0.39 | - |
Returns for 1 year | -5.17 | 4.11 | -126% |
Returns for 3 years | 22.32 | 33.01 | 68% |
Returns for 5 years | 68.75 | 114.93 | 60% |
Returns for 10 years | 130.39 | 232.42 | 56% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RXL | 42.66 | 1.26 | +3.06% |
ProShares Ultra Health Care | |||
FEZ | 52.75 | 0.99 | +1.91% |
SPDR® EURO STOXX 50 ETF | |||
RFV | 103.79 | 1.63 | +1.60% |
Invesco S&P MidCap 400® Pure Value ETF | |||
SMDV | 60.82 | 0.44 | +0.73% |
ProShares Russell 2000 Dividend Growers | |||
RBLD | 63.03 | N/A | N/A |
First Trust Alerian US NextGen InfrasETF |